Open AccessSustained Partial Response to Afatinib in a Patient With Lung Adenocarcinoma Harboring HER2V659E Mutation
Author(s) -
LingKai Chang,
JinYuan Shih
Publication year - 2020
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.20.00114
Subject(s) - afatinib , mutation , adenocarcinoma , lung , medicine , oncology , cancer research , genetics , biology , cancer , gefitinib , gene , epidermal growth factor receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom